No Strong Zika-GBS Link in Pacific Islands

Past outbreaks of the viral infection did not result in an increase in Guillain-Barré syndrome among children in the Pacific, according to a study; plus, more sexually transmitted Zika cases reported

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PUBLIC HEALTH IMAGE LIBRARY, JAMES GATHANYZika’s march through Latin America is thought to be tied to a rise in instances of Guillain-Barré syndrome (GBS), a serious neurological disorder. A new study, published February 19 in the Bulletin of the World Health Organization, has found that among eight countries and regions in the Pacific with Zika outbreaks since 2007, only one—the Solomon Islands in 2015—experienced an increase in GBS numbers among children.

“This could represent confirmation of the utility of increased [GBS] detection for signaling the appearance of Zika virus, or reflect more sensitive public health surveillance following a major cyclone, or be a chance finding given that it was the only country where this occurred,” Adam Craig of the University of Newcastle, Australia, and colleagues wrote in their report.

Craig’s team collected surveillance data on GBS for children under 15 years old, and compared the timing of those cases with outbreaks of Zika. According to the study, the Solomon Islands had a Zika outbreak last year, when nine children were diagnosed with GBS, as opposed to an expected number of two diagnoses.

In other regions with Zika outbreaks, GBS cases did not go up concurrently. “We ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies